TIME magazine covers a new report suggesting that many medical reviewers who work for the FDA go on to work for the drug companies they were responsible for regulating. “I don’t think there is overt collusion going on, but if you know in the back of your mind that a major career opportunity after the FDA is going to work on the other side of the table, I worry it can make you less likely to put your foot down,” says study author Dr. Vinay Prasad, an assistant professor of medicine at the Oregon Health and Science University. “Regulators may be less willing to be very tough, and I worry that is happening.”
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.